Insulet Downgrade Scuttles Insulin System Maker (PODD)
June 20, 2008 · Filed Under Diabetes
Insulet Corporation (NASDAQ: PODD) is seeing shares hit pretty hard today on strong volume. The news is that Canaccord Adams issued an stock ratings Downgrade this morning and it slashed its prior Buy rating down to an unenthusiastic Hold rating. Of all the analysts that cover the stock, this is the first rating to go cautious on the stock. The medical device company of an insulin infusion system for people with insulin-dependent diabetes is down over 9% today at $16.14. This one has been public for a just over a year.
Jon Ogg
June 20, 2008